Your browser doesn't support javascript.
loading
Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats.
Molobekova, Camilla A; Kondaurova, Elena M; Ilchibaeva, Tatiana V; Rodnyy, Alexander Ya; Stefanova, Natalia A; Kolosova, Nataliya G; Naumenko, Vladimir S.
Afiliación
  • Molobekova CA; Federal Research Center, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentyeva Ave. 10, Novosibirsk, 630090, Russia.
  • Kondaurova EM; Federal Research Center, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentyeva Ave. 10, Novosibirsk, 630090, Russia.
  • Ilchibaeva TV; Federal Research Center, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentyeva Ave. 10, Novosibirsk, 630090, Russia.
  • Rodnyy AY; Federal Research Center, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentyeva Ave. 10, Novosibirsk, 630090, Russia.
  • Stefanova NA; Federal Research Center, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentyeva Ave. 10, Novosibirsk, 630090, Russia.
  • Kolosova NG; Federal Research Center, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentyeva Ave. 10, Novosibirsk, 630090, Russia.
  • Naumenko VS; Federal Research Center, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentyeva Ave. 10, Novosibirsk, 630090, Russia.
Curr Alzheimer Res ; 20(7): 496-505, 2023.
Article en En | MEDLINE | ID: mdl-37641989
AIM: In this study, OXYS rats of three ages (1, 3, and 6 months), a proven model of Alzheimer's disease (AD), at various stages of disease progression were used to thoroughly study the effects of amisulpride on behavior and tau protein phosphorylation. BACKGROUND: With the growing number of patients with AD, the problem of finding a cure is very acute. Neurodegeneration in AD has various causes, one of which is hyperphosphorylation of tau protein. OBJECTIVE: This study aimed to investigate whether amisulpride would affect pathological tau phosphorylation in AD. METHODS: We assessed the influence of chronic administration of amisulpride (3 weeks, 3 mg/kg per day, intraperitoneally)-a 5-HT7 receptor inverse agonist-on behavior and tau hyperphosphorylation in OXYS rats (at ages of 1, 3, and 6 months). RESULTS: Chronic administration of amisulpride dramatically decreased tau phosphorylation in the frontal cortex and hippocampus of 3-month-old OXYS rats. Additionally, in 1- and 3-month-old rats' hippocampi, amisulpride diminished the mRNA level of the Cdk5 gene encoding one of the main tau kinases involved in the 5-HT7 receptor-induced effect on tau phosphorylation. CONCLUSION: Thus, We found that chronic administration of amisulpride could reduce pathological tau hyperphosphorylation while reducing anxiety. We propose amisulpride to have therapeutic potential against AD and that it can be the most effective in the early stages of the disease.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas tau / Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Infant Idioma: En Revista: Curr Alzheimer Res Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Emiratos Árabes Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas tau / Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Infant Idioma: En Revista: Curr Alzheimer Res Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Emiratos Árabes Unidos